Clinical trial
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients…
NCT00106314 · Inflabloc Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00106314 |
|---|---|
| Title | An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease |
| Official title | A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease |
| Lead sponsor | Inflabloc Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Dehydroepiandrosterone [DHEA] |
| Enrollment | 75 |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Mar 23, 2005 |
| Last update posted | Oct 19, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: